Biodesix (BDSX) EPS (Weighted Average and Diluted) (2021 - 2025)
Historic EPS (Weighted Average and Diluted) for Biodesix (BDSX) over the last 5 years, with Q3 2025 value amounting to -$1.16.
- Biodesix's EPS (Weighted Average and Diluted) rose 1714.29% to -$1.16 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.96, marking a year-over-year increase of 33157.89%. This contributed to the annual value of -$0.33 for FY2024, which is 4847.98% up from last year.
- Latest data reveals that Biodesix reported EPS (Weighted Average and Diluted) of -$1.16 as of Q3 2025, which was up 1714.29% from -$0.08 recorded in Q2 2025.
- In the past 5 years, Biodesix's EPS (Weighted Average and Diluted) ranged from a high of -$0.06 in Q4 2024 and a low of -$4.52 during Q2 2021
- Its 5-year average for EPS (Weighted Average and Diluted) is -$0.59, with a median of -$0.29 in 2022.
- In the last 5 years, Biodesix's EPS (Weighted Average and Diluted) skyrocketed by 9269.32% in 2022 and then tumbled by 90000.0% in 2024.
- Biodesix's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.49 in 2021, then soared by 32.65% to -$0.33 in 2022, then surged by 72.73% to -$0.09 in 2023, then increased by 28.01% to -$0.06 in 2024, then plummeted by 1690.47% to -$1.16 in 2025.
- Its last three reported values are -$1.16 in Q3 2025, -$0.08 for Q2 2025, and -$0.08 during Q1 2025.